|
|
Blood, 1 February 2007, Vol. 109, No. 3, pp. 961-970.
Prepublished online as a Blood First Edition Paper on September 29, 2006October 17, 2006; DOI 10.1182/blood-2006-07-036640.
 Previous Article | Next Article 
Submitted July 24, 2006
Accepted September 16, 2006
Commonly dysregulated genes in murine APL cells
Wenlin Yuan, Jacqueline E Payton, Matthew S Holt, Daniel C Link, Mark A Watson, John F DiPersio, and Timothy J Ley*
Washington University, United States
* Corresponding author; email: timley{at}im.wustl.edu.
To identify genes that are commonly dysregulated in a murine model of acute promyelocytic leukemia, we first defined gene expression patterns during normal murine myeloid development; serial gene expression profiling studies were performed with primary murine hematopoietic progenitors that were induced to undergo myeloid maturation in vitro with G-CSF. Many genes were reproducibly expressed in restricted developmental "windows," suggesting a structured hierarchy of expression that is relevant for the induction of developmental fates and/or differentiated cell functions. We compared the normal myeloid developmental transcriptome to that of APL cells derived from mice expressing PML-RAR under control of the murine cathepsin G locus. While many promyelocyte-specific genes were highly expressed in all APL samples, 116 genes were reproducibly dysregulated in many independent APL samples, including Fos, Jun, Egr-1, TNF, and VCAM-1. However, this set of commonly dysregulated genes was expressed normally in preleukemic, early myeloid cells from the same mouse model, suggesting that dysregulation occurs as a "downstream" event during disease progression. These studies suggest that the genetic events that lead to APL progression may converge on common pathways that are important for leukemia pathogenesis.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
What unleashes aberrant gene regulation in acute promyelocytic leukemia?
- Jonathan D. Licht
Blood 2007 109: 857.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
B. Nervi, P. Ramirez, M. P. Rettig, G. L. Uy, M. S. Holt, J. K. Ritchey, J. L. Prior, D. Piwnica-Worms, G. Bridger, T. J. Ley, et al.
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Blood,
June 11, 2009;
113(24):
6206 - 6214.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Licht
Acute Promyelocytic Leukemia -- Weapons of Mass Differentiation
N. Engl. J. Med.,
February 26, 2009;
360(9):
928 - 930.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Wouters, B. Lowenberg, and R. Delwel
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
Blood,
January 8, 2009;
113(2):
291 - 298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zhang, L.-P. Song, Y. Huang, Q. Zhao, K.-W. Zhao, and G.-Q. Chen
Accumulation of hypoxia-inducible factor-1{alpha} protein and its role in the differentiation of myeloid leukemic cells induced by all-trans retinoic acid
Haematologica,
October 1, 2008;
93(10):
1480 - 1487.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Tomasson, Z. Xiang, R. Walgren, Y. Zhao, Y. Kasai, T. Miner, R. E. Ries, O. Lubman, D. H. Fremont, M. D. McLellan, et al.
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
Blood,
May 1, 2008;
111(9):
4797 - 4808.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Heuser, B. Argiropoulos, F. Kuchenbauer, E. Yung, J. Piper, S. Fung, R. F. Schlenk, K. Dohner, T. Hinrichsen, C. Rudolph, et al.
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML
Blood,
September 1, 2007;
110(5):
1639 - 1647.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
